FGF21-receptor agonists: an emerging therapeutic class for obesity-related diseases
When activated, it promotes fat oxidation, increases glucose uptake in skeletal muscle, reduces inflammation, and enhances cellular stress resistance
There are a number of these clinical trials underway to test GLP-1 agonists for the treatment of various substance use disorders, including nicotine, alcohol, opioids and cocaine, she says, remarking that for alcohol, there has so far been only one trial that has posted results
However, Flow Wellness recommends seeking immediate medical attention if redness is accompanied by widespread hives, facial swelling, vomiting, dizziness, or difficulty breathing, as these may indicate a serious allergic reaction
The announcement comes in a climate of global market shortage of GLP-1s as demand massively overtakes supply
It is a powerful tool to be used alongside healthy lifestyle choices